Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 2/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14557202 | 0.91 | HSPA5 (0.74) | HSPA5GABRA1GABRB2KMT2AALDH1A1 | |
| SCHEMBL2070812 | 0.88 | HSPA5 (0.53) | HSPA5KMT2AALDH1A1MEN1TSHR | |
| SCHEMBL3809037 | 0.86 | HSPA5 (0.46) | HSPA5GABRA1GABRB2KMT2AALDH1A1 | |
| SCHEMBL7792869 | 0.85 | HSPA5 (0.45) | HSPA5ALDH1A1TSHRHIF1ACYP1A2 | |
| SCHEMBL57329 | 0.85 | HSPA5 (0.82) | HSPA5KMT2AALDH1A1MEN1TSHR | |
| SCHEMBL2910785 | 0.84 | HSPA5 (0.44) | HSPA5GABRA1GABRB2KMT2AALDH1A1 | |
| SCHEMBL7796395 | 0.82 | HSPA5 (0.43) | HSPA5KMT2AMEN1TSHRHIF1A | |
| SCHEMBL1174207 | 0.81 | HSPA5 (0.55) | HSPA5GABRA1GABRB2ALDH1A1HIF1A | |
| SCHEMBL17471441 | 0.81 | ESR1 (0.42) | HSPA5GABRA1GABRB2KMT2AALDH1A1 | |
| SCHEMBL10454472 | 0.80 | HSPA5 (0.39) | HSPA5GABRA1GABRB2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812543-B2 | STABILIZED PROPYL BROMIDE COMPOSITIONS | ALBEMARLE CORP (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8129325-B2 | mononuclear phenolic compound free of unsaturation, such as 2,6-Di-tert-butyl-4-methylphenol as stabilizer; use cold cleaning of electrical and mechanical parts | ALBERMARLE CORPORATION (US) | 2012-03-06 | — | — | US | disclosed |
| CN-101171218-B | 1-bromopropane having low acidity | ALBEMARLE CORP. (US) | 2011-12-07 | — | — | CN | disclosed |
| CN-101052704-B | Stabilized propyl bromide compositions | ALBEMARLE CORP | 2011-03-23 | — | — | CN | disclosed |
| EP-1812543-B1 | STABILIZED PROPYL BROMIDE COMPOSITIONS | ALBEMARLE CORP (US) | 2010-04-21 | — | — | EP | disclosed |
| US-20090253608-A1 | Stabilized Propyl Bromide Compositions | ALBEMARLE CORPORATION (US) | 2009-10-08 | — | — | US | disclosed |
| US-20080177116-A1 | 1-Bromopropane Having Low Acidity | ALBEMARLE CORPORATION (US) | 2008-07-24 | — | — | US | disclosed |
| CN-101171218-A | 1-bromopropane having low acidity | ALBEMARLE CORP (US) | 2008-04-30 | — | — | CN | disclosed |
| EP-1883615-A2 | 1-BROMOPROPANE HAVING LOW ACIDITY | ALBEMARLE CORPORATION (US) | 2008-02-06 | — | — | EP | disclosed |
| CN-101052704-A | Stabilized propyl bromide compositions | ALBEMARLE CORP (US) | 2007-10-10 | — | — | CN | disclosed |
| EP-1812543-A1 | STABILIZED PROPYL BROMIDE COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006119212-A2 | 1-BROMOPROPANE HAVING LOW ACIDITY | ALBEMARLE CORPORATION (US) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006052241-A1 | STABILIZED PROPYL BROMIDE COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253608-A1 | Stabilized Propyl Bromide Compositions | PGGT1B, TERB1, NFKB2 | HSPA5 228/4885GABRA1 1329/4885GABRB2 277/4885 |
| US-20080177116-A1 | 1-Bromopropane Having Low Acidity | BET1, BRD1, BRD4 | HSPA5 2029/4885GABRA1 117/4885GABRB2 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.